Carregant...
Secretogranin III as a novel target for the therapy of choroidal neovascularization
Wet age-related macular degeneration (AMD) with choroidal neovascularization (CNV) is a leading cause of vision loss in the elderly. The advent of anti-vascular endothelial growth factor (VEGF) drugs represents a major breakthrough in wet AMD therapy but with limited efficacy to improve visual acuit...
Guardat en:
| Publicat a: | Exp Eye Res |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6443442/ https://ncbi.nlm.nih.gov/pubmed/30633921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exer.2019.01.009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|